有蹄类动物相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
41	GR SSENVERSTELLBARER SCHUH FÜR HUFTIERE	EP03811703.2	2003-11-17	EP1565054A1	2005-08-24	Maestrini, Manolo
The invention relates to a size-adjustable shoe for hoofed animals, comprising at least one protective part (20) and a fixing part (30). Said protective part (20) is provided with at least one sole (21), a cap (22) that extends in the front and on both sides, and a fastening device (23) while the fixing part (30) is provided with at least one heel part (32), two lateral straps, and a fastening device (34). The heel part (32) can be mounted on the sole at an adjustable distance while the fastening devices (23) allow the hoof shoe (10) to be tightly fixed to the hoof.
42	GRÖSSENVERSTELLBARER SCHUH FÜR HUFTIERE	EP03811703.2	2003-11-17	EP1565054B1	2006-11-15	Maestrini, Manolo
The invention relates to a size-adjustable shoe for hoofed animals, comprising at least one protective part (20) and a fixing part (30). Said protective part (20) is provided with at least one sole (21), a cap (22) that extends in the front and on both sides, and a fastening device (23) while the fixing part (30) is provided with at least one heel part (32), two lateral straps, and a fastening device (34). The heel part (32) can be mounted on the sole at an adjustable distance while the fastening devices (23) allow the hoof shoe (10) to be tightly fixed to the hoof.
43	Determination of pregnancy status in ungulate ruminants	US11520403	2006-09-13	US08658431B2	2014-02-25	Troy L. Ott
A method and kit for determining whether an animal is not pregnant, or is pregnant following a breeding. The level of expression of a pregnancy induced protein is determined in an animal for which pregnancy status information is desired and the level is compared to that of the level in animals that are not pregnant.
44	Cloning ungulates from a quiescent donor cell	US10915338	2004-08-11	US07232938B2	2007-06-19	Keith Henry Stockman Campbell; Ian Wilmut
A method of reconstituting an animal embryo involves transferring the nucleus from a quiescent donor cell into a suitable recipient cell. The donor cell is quiescent, in that it is caused to exit from the growth and division cycle at G1 and to arrest in the G0 state. Nuclear transfer may take place by cell fusion. The reconstituted embryo may then give rise to one or more animals. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
45	IMMUNOCOMPROMISED UNGULATES	EP09824080.7	2009-10-27	EP2348827A1	2011-08-03	AYARES, David, L.; MENDICINO, Michael; WELLS, Kevin; DANDRO, Amy, S.
Porcine animals, tissue and organs as well as cells and cell lines derived from such animals are provided that lack functional endogenous immunoglobulin loci and are deficient in immunoglobulin expression and B-cells. These animals are useful as model systems for research and for development of new pharmaceutical and biological agents. In addition, metho ds are provided to prepare such animals.
46	COMPOSITION FOR THE TREATMENT OF HOOF CONDITIONS IN HOOFED ANIMALS	EP99917233.1	1999-04-01	EP1067835A1	2001-01-17	Vroom, René Werenfridus Lodewijk
Composition for the topical treatment of hooves of hoofed animals comprising a curing agent preferably comprising bay leaf oil and/or turpentine oil and a fungicide, and optionally a bactericide. A method for the preparation of the composition. A method of treatment of hooves of hoofed animals suffering from white line disease, hoof thrush and/or hoof rot. Use of a fungicide and optionally a bactericide in the manufacture of a composition for topical treatment of diseased hooves of hoofed animals.
47	Ungulates with genetically modified immune systems	US11257817	2005-10-24	US20060130157A1	2006-06-15	Kevin Wells; David Ayares
The present invention provides ungulate animals, tissue and organs as well as cells and cell lines derived from such animals, tissue and organs, which lack expression of functional endogenous immunoglobulin loci. The present invention also provides ungulate animals, tissue and organs as well as cells and cell lines derived from such animals, tissue and organs, which express xenogenous, such as human, immunoglobulin loci. The present invention further provides ungulate, such as porcine genomic DNA sequence of porcine heavy and light chain immunogobulins. Such animals, tissues, organs and cells can be used in research and medical therapy. In addition, methods are provided to prepare such animals, organs, tissues, and cells.
48	Ungulates produced by nuclear transfer of G1 cells	US09989125	2001-11-21	US07304204B2	2007-12-04	Keith Henry Stockman Campbell; Ian Wilmut
A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
49	Transgenic ungulate compositions and methods	US08410539	1995-03-24	US07071373B1	2006-07-04	Matthew B. Wheeler
Transgenic ungulates and compositions and methods for making and using same, are provided. Central to the invention are porcine, bovine, ovine and caprine embryonic stem cell lines and methods for establishing them. Cells of such lines are transformed with exogenous genetic material of interest and then used to provide chimeric ungulates confirmed by genetic markers which have germ cells comprising the exogenous genetic material. The chimeric ungulates are bred to provide transgenic ungulates. The transgenic animals of the invention may show improved qualities and can be used to provide human proteins or peptide hormones or can be used as xenograft donors.
50	Ungulate game animal feed system and method	US09916637	2001-07-26	US20030019437A1	2003-01-30	John Fore
An ungulate game animal feeder and attracter system that includes a housing having a hopper area, and a feed material processor unit that utilizes whole, fleshy vegetable matter feed items, such as potatoes, carrots, apples, sweet potatoes, sugar beets, etc., as the feed material. During operation of the ungulate game animal feeder and attracter system, the whole fleshy vegetable matter feed items are processed by the feed material processor unit to form feed material sub-portions of the whole, fleshy vegetable matter feed items, such as slices, chunks, pulp, puree, etc., in a manner such that an attractant scent is given off. The processed feed material is discharged for the ungulate game animals attracted by the smell given of during the forming of the feed material sub-portions to feed on. In some embodiments, juice is also generated during the formation of the sub-portions and falls from the feeder and attracter system and is absorbed by the soil near the ungulate game animal feeder and attracter system in a manner to provide a second ungulate game animal attractant mechanism.
51	Method of producing a polypeptide in an ungulate	US09354276	1999-07-15	US06395958B1	2002-05-28	Nikolai S. Strelchenko; Jeffrey M. Betthauser; Gail L. Jurgella; Marvin M. Pace; Michael D. Bishop
The present invention relates to cloning technologies. The invention relates in part to immortalized and totipotent cells useful for cloning animals, the embryos produced from these cells using nuclear transfer techniques, animals that arise from these cells and embryos, and materials, methods, and processes for establishing such cells, embryos, and animals.
52	IMMUNOCOMPROMISED UNGULATES	EP09824080	2009-10-27	EP2348827A4	2012-03-28	AYARES DAVID L; MENDICINO MICHAEL; WELLS KEVIN; DANDRO AMY S

53	Unactivated ungulate oocytes to produce a cloned ungulate by nuclear transfer	US10914161	2004-08-10	US07321076B2	2008-01-22	Keith Henry Stockman Campbell; Ian Wilmut
A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
54	Unactivated ungulate oocytes to produce a transgenic ungulate by nuclear transfer	US10190617	2002-07-09	US07326824B2	2008-02-05	Keith Henry Stockman Campbell; Ian Wilmut
A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
55	REINIGUNGSVORRICHTUNG ZUM REINIGEN EINES HUFS EINES HUFTIERS	PCT/EP2010/067870	2010-11-20	WO2011067126A1	2011-06-09	WIJEYRATNE, Norman
Die Erfindung betrifft eine Reinigungsvorrichtung (1) zum Reinigen eines Hufs eines Huftiers, umfassend ein drehantreibbares bürstenartiges Element (2), das zur automatischen Reinigung des Hufs des Huftiers drehbar um eine Drehachse (21) gelagert ist. Dabei ist ein mit Öffnungen (31) versehenes Trennelement (3) vorgesehen, durch welches eine Bürste (22, 221) des bürstenartigen Elements (2) im Betriebszustand derart rotierend hervortritt, dass die Bürste (22, 221 ) in bürstenden Kontakt mit dem auf dem Trennelement (3) angeordneten Huf des Huftiers bringbar ist. Erfindungsgemäss ist zur Benetzung des Hufs mit einer Benetzungssubstanz (41) das Trennelement (3) zwischen der Drehachse (21) des bürstenartigen Elements (2) und einem Benetzungsmittel (4) vorgesehen.
56	BEDDING FOR UNGULATES AND ITS RECYCLING INTO COMPOST	EP13731860.6	2013-05-08	EP2846626B1	2016-12-21	VOLNER, Matija
The invention relates to a bedding for ungulate and other animals, consisting of dust- freed wood pellets or sawdust and nutrient medium for composting bacteria. The nutrient agent is based on the brown alga, preferably Ascophyllum nodosum. The bedding is supplemented with medicinal herbs selected from: lavender (Lavandula angustifolia), lavandin [Lavandula x intermedia), laurel (Laurus nobilis), marigold (Calendula officinalis) and Lemon balm (Mellisa officinalis). The patent further relates to the bedding composting procedure, and the use of the bedding as a preventive agent against lesions and pneumonia in animals in intensive farming.
57	CULTURED INNER CELL MASS CELL LINES DERIVED FROM UNGULATE EMBRYOS	EP97915189	1997-03-24	EP0938550A4	2001-08-08	STICE STEVEN L; GOLUEKE PAUL J

58	IMMUNOCOMPROMISED UNGULATES	EP09824080.7	2009-10-27	EP2348827B1	2015-07-01	AYARES, David, L.; MENDICINO, Michael; WELLS, Kevin; DANDRO, Amy, S.

59	Ungulates with genetically modified immune systems	US12433477	2009-04-30	US09585374B2	2017-03-07	Kevin Wells; David Ayares
The present invention provides ungulate animals, tissue and organs as well as cells and cell lines derived from such animals, tissue and organs, which lack expression of functional endogenous immunoglobulin loci. The present invention also provides ungulate animals, tissue and organs as well as cells and cell lines derived from such animals, tissue and organs, which express xenogenous, such as human, immunoglobulin loci. The present invention further provides ungulate, such as porcine genomic DNA sequence of porcine heavy and light chain immunogobulins. Such animals, tissues, organs and cells can be used in research and medical therapy. In addition, methods are provided to prepare such animals, organs, tissues, and cells.
60	Method of cloning animals	US09688782	2000-10-16	US06603059B1	2003-08-05	Nikolai S. Strelchenko; Jeffrey M. Betthauser; Gail L. Jurgella; Marvin M. Pace; Michael D. Bishop
The present invention relates to cloning technologies. The invention relates in part to immortalized and totipotent cells useful for cloning animals, the embryos produced from these cells using nuclear transfer techniques, animals that arise from these cells and embryos, and materials, methods, and processes for establishing such cells, embryos, and animals.

1 2 3 4 5 6 7 8 9 10

IPRDB

热门服务

关于我们

友情链接

联系方式